NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,165 | -21.1% | 2,024 | -21.9% | 0.01% | -20.0% |
| Q2 2023 | $261,458 | +2.0% | 2,591 | -7.0% | 0.02% | +7.1% |
| Q1 2023 | $256,404 | -8.4% | 2,787 | -9.7% | 0.01% | -12.5% |
| Q4 2022 | $279,871 | -8.5% | 3,085 | -23.4% | 0.02% | -23.8% |
| Q3 2022 | $306,000 | -27.0% | 4,026 | -18.8% | 0.02% | -30.0% |
| Q2 2022 | $419,000 | -59.4% | 4,957 | -57.8% | 0.03% | -60.5% |
| Q1 2022 | $1,032,000 | -14.7% | 11,757 | -15.0% | 0.08% | -8.4% |
| Q4 2021 | $1,210,000 | -10.8% | 13,838 | -16.6% | 0.08% | -25.2% |
| Q3 2021 | $1,357,000 | -11.4% | 16,593 | -1.8% | 0.11% | -10.5% |
| Q2 2021 | $1,532,000 | +5.1% | 16,889 | -1.0% | 0.12% | -11.4% |
| Q1 2021 | $1,458,000 | -24.2% | 17,061 | -16.3% | 0.14% | -25.5% |
| Q4 2020 | $1,924,000 | – | 20,380 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |